Acceleron Pharma News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.06.21	BMY, Acceleron Announce New Data From Reblozyl Phase 2 Trial For Adults With NTD Beta Thalassemia (RTTNews)
29.09.20	Bristol Myers, Acceleron Pharma Announce Health Canada Approval Of Reblozyl (RTTNews)
28.01.20	XLRN Soars, FDA Approves Triple Combo Pill For Type 2 Diabetes, MGEN On Watch (RTTNews)
27.01.20	Acceleron Pharma Reports Positive Topline Results From PULSAR Trial (RTTNews)
11.11.19	FDA Approves Celegene's Reblozyl To Treat An Inherited Blood Disorder (RTTNews)
17.09.19	XLRN Pulls The Plug On FSHD Study, KPTI Well Funded, ACRS Up On Wart Trial Data (RTTNews)
17.09.19	Acceleron Pharma's ACE-083 Fails In Phase 2 Study For FSHD (RTTNews)
06.08.19	ALNY To Face FDA In Feb., PODD Ups Outlook Again, Catalysts Galore For XLRN (RTTNews)
03.12.18	XLRN On Watch, BPMC Makes An Imprint, Osteoporosis Drug Evenity Faces FDA Panel (RTTNews)
29.09.18	Week Ahead In Pharmaceuticals: 5 Stocks To Watch (OMER, BOLD, XLRN...) (RTTNews)
04.09.18	Is There Still Room To Run For These Biotech Stocks? (RTTNews)
14.07.18	Week Ahead In Pharmaceuticals - 7 Stocks To Watch (RTTNews)
10.07.18	ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN (RTTNews)
07.07.18	Week Ahead In Pharmaceuticals - Stocks To Watch (RTTNews)
03.06.18	An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...) (RTTNews)
21.05.18	Positivity is Key When Saying Goodbye to a Valued Employee, Says Brandon Frere (PR Newswire)
09.01.18	Parkinson's Drug Hits Shelves, Major Event Awaits ABIO In Mar, FDA Nod For NVRO (RTTNews)
02.01.18	KDMN And 10 Other Biotech Stocks You Should Watch This Month (RTTNews)
22.12.17	APLS Sets Out Its Vision, APEN Gains Weight, Packed Year Ahead For DRNA (RTTNews)
02.10.17	A Tail of Two Cities: Vancouver and Edmonton have the Country's Most Pampered Pets (PR Newswire)
22.09.17	IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns (RTTNews)
21.09.17	FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ (RTTNews)
27.06.17	Gainers & Losers Of June 26: AVEO, MBRX, SELB, NEOT, SGEN... (RTTNews)
13.06.17	XLRN's DART Misses Mark, RGLS Makes Cuts In Pipeline, FDA Snubs CHRS (RTTNews)
18.05.17	Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... (RTTNews)
09.05.17	Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD... (RTTNews)
02.05.17	Die führende Proteinwissenschaftlerin Dr. Asya Grinberg kommt als Leitern des Bereiches Biologics zu Dragonfly Therapeutics (PR Newswire)
02.05.17	La Dre Asya Grinberg, scientifique spécialisée en protéines, rejoint Dragonfly Therapeutics à titre de dirigeante du service biologique (PR Newswire)
01.05.17	Leading Protein Scientist Dr. Asya Grinberg Joins Dragonfly Therapeutics as Head of Biologics (PR Newswire)
01.05.17	Leading Protein Scientist Dr. Asya Grinberg Joins Dragonfly Therapeutics as Head of Biologics (PR Newswire)
02.03.17	Research Reports Coverage on Healthcare Stocks -- Novan, Acceleron Pharma, and Meridian Bioscience (PR Newswire)
05.12.16	Acceleron, Celgene Announce Preliminary Results From Sotatercept Phase 2 Study (RTTNews)
05.12.16	ALNY In Motion, Shire Finds New Use For Old Drug, TFX Snaps Up VASC (RTTNews)
05.12.16	ALNY In Motion, Shire Finds New Use For Old Drug, TFX Snaps Up VASC (RTTNews)
10.06.16	Acceleron, Celgene Announce Promising Results From 3-month Luspatercept Trial (RTTNews)
07.12.15	FDA Grants Fast Track Designation To Luspatercept For Treating Lower-risk MDS (RTTNews)
12.06.15	Acceleron Announces New Luspatercept Phase 2 Results At The 20th EHA Congress (RTTNews)
02.03.15	AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
12.12.14	Acceleron Pharma Adds Francois Nader To Board - Quick Facts (RTTNews)
15.05.14	Acceleron Pharma Q1 Loss Widens - Quick Facts (RTTNews)
18.03.14	ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move (RTTNews)
23.01.14	Acceleron Prices Public Offering Of 2.4 Mln Shares At $50/shr, Before Discounts (RTTNews)
18.12.13	Acceleron To Receive $7 Mln Milestone Payment From Celgene - Quick Facts (RTTNews)
04.12.13	AMBI To Take A Long Route, ETRM Recharged, EXAS Gets Panel Date, OMED Flies High (RTTNews)
19.09.13	Acceleron Pharma Prices IPO At $15/Share, At Top End Of Estimated Range (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Acceleron Pharma Inc

Aktien Top/Flop

Acceleron Pharma Peer Group Nachrichten

Meistgelesene Nachrichten